Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel Scoring System for Ranking Hematopoietic Stem Cell Transplantation.
Baxter-Lowe LA, Wang T, Kuxhausen M, Spellman SR, Maiers M, Lee S, Saultz J, Arrieta-Bolaños E, Gadalla SM, Bolon YT, Betts BC. Baxter-Lowe LA, et al. Among authors: betts bc. Clin Transplant. 2024 Nov;38(11):e15478. doi: 10.1111/ctr.15478. Clin Transplant. 2024. PMID: 39512128
JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results.
Pidala J, Holtan SG, Walton K, Kim J, Cao B, Elmariah H, Mishra A, Bejanyan N, Nishihori T, Khimani F, Perez L, Faramand RG, Davila ML, McSain S, Pleskow J, Baron J, Anasetti C, Moran Segura C, Weisdorf DJ, Blazar BR, Miller JS, Bachanova V, El Jurdi N, Betts BC. Pidala J, et al. Among authors: betts bc. Blood. 2024 Nov 28;144(22):2295-2307. doi: 10.1182/blood.2024024789. Blood. 2024. PMID: 39046783 Free article. Clinical Trial.
Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors.
Herr MM, Balderman SR, Wallace PK, Zhang Y, Tario JD Jr, Buxbaum NP, Holtan S, Ross M, McCarthy PL, Betts B, Maslak P, Hahn TE. Herr MM, et al. Among authors: betts b. Transplant Cell Ther. 2024 Aug;30(8):808.e1-808.e13. doi: 10.1016/j.jtct.2024.05.018. Epub 2024 May 25. Transplant Cell Ther. 2024. PMID: 38801976
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD.
Etra A, El Jurdi N, Katsivelos N, Kwon D, Gergoudis S, Morales G, Spyrou N, Kowalyk S, Aguayo-Hiraldo P, Akahoshi Y, Ayuk F, Baez J, Betts BC, Chanswangphuwana C, Chen YB, Choe H, DeFilipp Z, Gleich S, Hexner E, Hogan WJ, Holler E, Kitko CL, Kraus S, Al Malki M, MacMillan M, Pawarode A, Quagliarella F, Qayed M, Reshef R, Schechter T, Vasova I, Weisdorf D, Wölfl M, Young R, Nakamura R, Ferrara JLM, Levine JE, Holtan S. Etra A, et al. Among authors: betts bc. Blood Adv. 2024 Jun 25;8(12):3284-3292. doi: 10.1182/bloodadvances.2023011049. Blood Adv. 2024. PMID: 38640195 Free PMC article.
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.
Boucher JC, Shrestha B, Vishwasrao P, Leick M, Cervantes EV, Ghafoor T, Reid K, Spitler K, Yu B, Betts BC, Guevara-Patino JA, Maus MV, Davila ML. Boucher JC, et al. Among authors: betts bc. Mol Ther Oncolytics. 2023 Nov 20;31:100751. doi: 10.1016/j.omto.2023.100751. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 38075241 Free PMC article.
119 results